Brigham and Women's Hospital 75 Francis Street, Boston, MA 02115
Greenberg Division of Cardiology 520 E 70Th St, New York, NY 10021
NewYork-Presbyterian/Weill Cornell Medical Center 525 East 68Th Street, New York, NY 10065
Education:
Medical School Columbia University College Of Physicians and Surgeons Graduated: 2001 Medical School Ny-Presby Hospital Columbia University Med Center Graduated: 2004 Medical School University Of Pennsylvania Graduated: 2004
Christopher Liu, Boston MA - PA (Physician assistant; also Posterior–anterior)
Dr. Liu graduated from the Columbia University College of Physicians and Surgeons in 2001. He works in New York, NY and specializes in Cardiovascular Disease. Dr. Liu is affiliated with New York Presbyterian Hospital Weill Cornell Medical Center and New York Presbyterian Westchester Division.
9501 Roosevelt Blvd, Philadelphia, PA 19114 3400 Spruce St, Philadelphia, PA 19104 525 E 68Th St, New York, NY 10065
Education:
Columbia University, College of Physicians and Surgeons - Doctor of Medicine Hospital of the University of Pennsylvania - Fellowship - Cardiac Electrophysiology Hospital of the University of Pennsylvania - Fellowship - Cardiovascular Disease (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine) American Board of Internal Medicine Sub-certificate in Clinical Cardiac Electrophysiology (Internal Medicine)
License Records
Christopher Fei-Yong Liu
Address:
Elmhurst, NY 11373
License #:
MT184538 - Expired
Category:
Medicine
Type:
Graduate Medical Trainee
Christopher C Liu
Phone:
4164490880
License #:
16313 - Expired
Category:
Health Care
Issued Date:
Jun 25, 2003
Effective Date:
Sep 30, 2016
Type:
Pharmacist Intern
Name / Title
Company / Classification
Phones & Addresses
Christopher Liu
CHRIS LIU | ATTONREY AT LAW, LLC
Christopher Liu Cardiovascular
Cornell Weill Medical College Hypertension Center · Medical Doctor's Office General Hospital
450 E 69 St, New York, NY 10021 2127462200
Christopher Liu Cardiovascular
Cornell University General Hospital College/University General Hospital · Medical Doctor's Office College/University
520 E 70 St, New York, NY 10021 2127462167, 2127464644
Christopher Liu President
Christopher Street Cleaners Entertainment · Drycleaning Plant
120 Christopher St #3, New York, NY 10014 2122428843
Us Patents
Antibiotic Compositions For The Treatment Of Gram Negative Infections
William V. Curran - Pear River NY, US Christopher M. Liu - Somerville MA, US Amy C. D. Bombardier - Waltham MA, US Richard A. Leese - Suffern NY, US You Seok Hwang - Concord MA, US Blaise S. Lippa - Acton MA, US Yanzhi Zhang - East Walpole MA, US
Assignee:
BioSource Pharm, Inc. - Spring Valley, New York NY Cubist Pharmaceuticals, Inc. - Lexington MA
Provided herein are novel compounds and novel protected compounds that can be derived from polymyxin, including, e. g. , polymyxin A. The novel compounds have antibacterial properties against a diverse range of Gram negative bacteria and reduced toxicity compared to polymyxins such as polymyxin A. Also provided are antibacterial pharmaceutical compositions containing the novel compounds and novel protected compounds, as well as methods for preparing the antibacterial compounds and protected compounds.
Degp Periplasmic Protease A New Anti-Infective Target And An In Vitro Assay For Degp Protease Function
Hal C. Jones - Corvallis OR Christopher Liu - Cambridge MA Scott J. Hultgren - Town and Country MO Dennis E. Hruby - Albany OR Christine A. Franke - Albany OR Amy K. Evans - West Linn OR
Assignee:
Washington University - St. Louis MO Siga Pharmaceuticals - New York NY
International Classification:
C12Q 137
US Classification:
435 23
Abstract:
The DegP (HtrA) protease is a multifunctional protein essential for the removal of misfolded and aggregated proteins in the periplasm. The present invention provides an assay for inhibitors of DegP activity, comprising mixing a suspected inhibitor of DegP activity with DegP and a suitable substrate (preferably a native substrate of DegP such as PapA) and detecting changes in DegP activity. DegP has been shown to be essential for virulence in several Gram negative pathogens. Only three natural targets for DegP have been described: colicin A lysis protein (Cal), pilin subunits (K88, K99, Pap) and recently HMW1 and HMW2 from Hemophilus influenzae. In vitro, DegP has shown weak protease activity on casein and several other non-native substrates. The present inventors have identified the major pilin subunit of the Pap pilus, PapA, as a native DegP substrate and demonstrated binding and proteolysis of this substrate in vitro. Using an NH. sub.
- Lexington MA, US Jonathan Lawrence - Lexington MA, US Madeline Rosini - Lexington MA, US Max Hecht - Lexington MA, US Christopher Matthew Liu - Somerville MA, US
Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing pathogen levels and/or abundance and for the treatment of related diseases.
Compositions of glycan polymers and methods of making and manufacturing the same are described herein. Also provided are methods of treating a disease or disorder with a glycan polymer preparation.
- Lexington MA, US Christopher Matthew Liu - Somerville MA, US Anastasia V. Murphy - North Attleboro MA, US
International Classification:
C08B 37/00
Abstract:
Preparations of glycan polymers and variations thereof, pharmaceutical compositions, medical foods, supplements, foods, food ingredients, feed ingredients, and feed additives thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same.
- Lexington MA, US Christopher Matthew Liu - Somerville MA, US Geoffrey A. von Maltzahn - Somerville MA, US Han Yuan - Arlington MA, US
International Classification:
A61K 31/716 A61K 9/00 A61P 3/00
Abstract:
Compositions of glycan polymers and methods of making and manufacturing the same are described herein. Also provided are methods of treating a disease or disorder with a glycan polymer preparation.
Inhibiting The Transient Receptor Potential A1 Ion Channel
- Cambridge MA, US Xinyuan Wu - Newton MA, US Qingyi Li - Somerville MA, US Iwona Wrona - Sharon MA, US Andrew J. Jackson - Waltham MA, US Bertrand L. Chenard - Waterford CT, US Christopher M. Liu - Somerville MA, US Guohua Liang - Acton MA, US Matthew F. Baevsky - Northborough MA, US Richard A. Earl - Westford MA, US Lisa Mcqueen - Phoenixville PA, US Jared Smit - Lafayette IN, US Brett A. Cowans - Lafayette IN, US
International Classification:
C07D 473/08
Abstract:
The present invention relates to compounds of the Formula (I), or a pharmaceutically acceptable salt, pharmaceutical preparation, or pharmaceutical composition thereof, and their use for the treatment of pain, inflammatory disease, neuropathy, dermatological disorders, pulmonary conditions, and cough, as well as inhibiting the Transient Receptor Potential A1 ion channel (TRPA1).
Inhibiting The Transient Receptor Potential A1 Ion Channel
- Cambridge MA, US Xinyuan Wu - Newton MA, US Qingyi Li - Somerville MA, US Iwona Wrona - Sharon MA, US Andrew J. Jackson - Waltham MA, US Bertrand L. Chenard - Waterford CT, US Christopher Matthew Liu - Somerville MA, US Guohua Liang - Acton MA, US Matthew F. Baevsky - Northborough MA, US Richard Alan Earl - Westford MA, US Lisa Mcqueen - Phoenixville PA, US Jared Smit - Lafayette IN, US Brett A. Cowans - West Lafayette IN, US
International Classification:
C07D 473/08
Abstract:
The present invention relates to compounds of the Formula (I), or a pharmaceutically acceptable salt, pharmaceutical preparation, or pharmaceutical composition thereof, and their use for the treatment of pain, inflammatory disease, neuropathy, dermatological disorders, pulmonary conditions, and cough, as well as inhibiting the Transient Receptor Potential A1 ion channel (TRPA1).
Youtube
End Of Days - RhetOracle Dance Company
RhetOracle Dance Company's piece for Pulse 2008 which will also appear...
Category:
Entertainment
Uploaded:
04 Apr, 2008
Duration:
7m 20s
The Ties
Danced by RhetOracle Dance Company. Choreographed by Christopher Liu. ...
Category:
Entertainment
Uploaded:
19 May, 2010
Duration:
6m 22s
Interviews with Lucy Liu, Abigail Breslin, Ch...
A preview of shows opening this Spring, featuring interviews with Lucy...
Category:
Entertainment
Uploaded:
29 Mar, 2010
Duration:
4m 32s
Christopher Lee and Jesseca Liu NG for ten mi...
Christopher Lee and Jesseca Liu NG for ten minutes!
Category:
Entertainment
Uploaded:
14 Jan, 2011
Duration:
5m 4s
Emotional Suffocation (The Struggle/Defeat)
This is a piece Christopher Monteith choreographed for The Post Concer...
LA, SF, NY, Sha, BJ, HK, SG, Tokyo, SeoulCEO at Privy Privy is a private global network and travel resource for a select group of transpacific executives and key influencers. Privy functions as a social compass... Privy is a private global network and travel resource for a select group of transpacific executives and key influencers. Privy functions as a social compass that enables like-minded people who travel frequently within and to Asia to share lifestyle reviews and coordinate roving itineraries in a...